+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Nocturnal Enuresis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768127
  • Report
  • April 2019
  • Region: Global
  • 72 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Eli Lilly and Co
  • Ferring Holding SA
  • GP Pharm SA
  • Seipel Group Pty Ltd
  • MORE
The global clinical trial report- “2019 Nocturnal Enuresis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturnal Enuresis. It presents in-depth analysis of Nocturnal Enuresis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Nocturnal Enuresis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Nocturnal Enuresis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Nocturnal Enuresis

The research work is prepared through extensive and continuous research on Nocturnal Enuresis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Nocturnal Enuresis patients are identified
  • The report includes panorama of Nocturnal Enuresis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Nocturnal Enuresis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Eli Lilly and Co
  • Ferring Holding SA
  • GP Pharm SA
  • Seipel Group Pty Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Nocturnal Enuresis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Nocturnal Enuresis Clinical Trials by Region
2.2.2 Average Enrollment of Nocturnal Enuresis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Nocturnal Enuresis Treatment, 2019

3. Region wise Nocturnal Enuresis Clinical Trials
3.1 Asia Pacific Nocturnal Enuresis Clinical Trials by Country
3.2 Europe Nocturnal Enuresis Clinical Trials by Country
3.3 North America Nocturnal Enuresis Clinical Trials by Country
3.4 Middle East and Africa Nocturnal Enuresis Clinical Trials by Country
3.5 South and Central America Nocturnal Enuresis Clinical Trials by Country

4. Nocturnal Enuresis Clinical Trial Trends
4.1 Start Year wise Nocturnal Enuresis Clinical Trials
4.2 Phase wise Nocturnal Enuresis Clinical Trials
4.3 Trial Status wise Nocturnal Enuresis Clinical Trials
4.4 Trial Type wise Nocturnal Enuresis Clinical Trials

5. Nocturnal Enuresis Average Enrollment Trends
5.1 Average Enrollment in Nocturnal Enuresis Trials by Year
5.2 Average Enrollment in Nocturnal Enuresis Trials by Phase
5.3 Average Enrollment in Nocturnal Enuresis Trials by Status
5.4 Average Enrollment in Nocturnal Enuresis Trials by Type of Trial

6. Companies Participating in Nocturnal Enuresis Clinical Trials
6.1 Nocturnal Enuresis Trials by Sponsor Type
6.2 Nocturnal Enuresis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Nocturnal Enuresis Trials- Phase 1
7.2 Nocturnal Enuresis Trials- Phase 2
7.3 Nocturnal Enuresis Trials- Phase 3
7.4 Nocturnal Enuresis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Nocturnal Enuresis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Figure 7: North America - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Figure 9: Nocturnal Enuresis Clinical Trials by Phase
Figure 10: Nocturnal Enuresis Clinical Trials by Trial Status
Figure 11: Nocturnal Enuresis Clinical Trials by Type
Figure 12: Nocturnal Enuresis Clinical Trials by Sponsor Type
Figure 13: Nocturnal Enuresis Clinical Trials by Leading Sponsors
Figure 14: Nocturnal Enuresis Average Enrollment by Phase
Figure 15: Nocturnal Enuresis Average Enrollment by Trial Status
Figure 16: Nocturnal Enuresis Average Enrollment by Type
Figure 17: Nocturnal Enuresis- Average Enrolment by Type of Sponsors
Figure 18: Nocturnal Enuresis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Nocturnal Enuresis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Table 5: Europe - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Table 7: North America - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Nocturnal Enuresis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Nocturnal Enuresis Average Enrollment by Phase
Table 15: Nocturnal Enuresis Average Enrollment by Trial Status
Table 16: Nocturnal Enuresis Average Enrollment by Type
Table 17: Nocturnal Enuresis- Average Enrolment by Type of Sponsors
Table 18: Nocturnal Enuresis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Eli Lilly and Co
  • Ferring Holding SA
  • Ferring Pharmaceuticals Pty Ltd
  • GP Pharm SA
  • Seipel Group Pty Ltd
Note: Product cover images may vary from those shown
Adroll
adroll